MktsMarkets

ADMA Biologics Inc
NASDAQ: ADMAKey statistics
ADMA News
Stories mentioning ADMA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 114,493 | 139,163 | 134,224 | 121,984 | 114,802 | 117,549 | 119,839 | 107,191 |
| Cost of Goods Sold | 33,743 | 50,348 | 58,598 | 54,757 | 53,705 | 54,216 | 60,180 | 49,738 |
| Gross Profit | 80,750 | 88,815 | 75,626 | 67,227 | 61,097 | 63,333 | 59,659 | 57,453 |
| Operating Expenses | ||||||||
| Research & Development | 2,597 | 1,377 | 1,528 | 1,031 | 826.00 | 391.00 | 412.00 | 560.00 |
| Sales General & Admin | 26,742 | 23,511 | 21,776 | 22,214 | 24,079 | 23,317 | 18,560 | 16,608 |
| Total Operating Expenses | 22,476 | 26,063 | 24,614 | 24,429 | 26,216 | 25,010 | 20,021 | 18,252 |
| Operating Income (Loss) | 58,274 | 62,752 | 51,012 | 42,798 | 34,881 | 38,323 | 39,638 | 39,201 |
| Interest Income | 487.00 | 376.00 | 400.00 | 608.00 | 598.00 | 666.00 | 449.00 | |
| Interest Expense | ||||||||
| Other Expense | (140.00) | (19.00) | (21.00) | (108.00) | (64.00) | (86.00) | (56.00) | (16.00) |
| Pretax Income | 57,127 | 61,594 | 47,515 | 40,097 | 33,450 | 34,713 | 36,749 | 35,851 |
| Tax Provision | 11,799 | 12,215 | 11,087 | 5,878 | 6,546 | (77,183) | 840.00 | 3,789 |
| Net Income (Loss) | 45,328 | 49,379 | 36,428 | 34,219 | 26,904 | 111,896 | 35,909 | 32,062 |
| Earnings Per Share (Basic) | 0.19 | 0.21 | 0.15 | 0.14 | 0.11 | 0.48 | 0.15 | 0.14 |
| Earnings Per Share (Diluted) | 0.19 | 0.20 | 0.15 | 0.14 | 0.11 | 0.46 | 0.15 | 0.13 |
| Weighted Average Shares Outstanding (Basic) | 236,073 | 238,299 | 238,603 | 241,491 | 237,775 | 233,084 | 234,571 | 232,418 |
| Weighted Average Shares Outstanding (Diluted) | 239,956 | 244,905 | 244,664 | 248,608 | 244,676 | 243,342 | 244,804 | 242,167 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ADMA
ADMA Biologics Inc (NASDAQ: ADMA) is a stock listed on the Nasdaq Stock Market under the ticker symbol ADMA. It last traded at $13.68 (Nov 13, 2026, 4:00 PM ET), up 3.3% on the day. That gives ADMA Biologics a market capitalisation of $2.9B and a price-to-earnings ratio of 17.4.
Over the past 52 weeks ADMA has traded between $7.21 and $20.46.
Revenue for the quarter ended Mar 31, 2026 was $114.5M; net income $45.3M. Revenue was down 0.3% from $114.8M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $114.5M | $45.3M | 39.6% |
| Dec 31, 2025 | $139.2M | $49.4M | 35.5% |
| Sep 30, 2025 | $134.2M | $36.4M | 27.1% |
| Jun 30, 2025 | $122.0M | $34.2M | 28.1% |
From ADMA Biologics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…